September 3, 2020
John Mazziotta, chief executive, UCLA Health.
Stories this photo appears in:
In one of the largest genomic medicine ventures in the nation, UCLA Health has entered into a research agreement with Regeneron Pharmaceuticals.
Custom Content by the Los Angeles Business Journal
Dr. John C. Mazziotta has been CEO of UCLA Health and vice chancellor of UCLA Health Sciences since 2015.